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Abstract 
 
Aims 
To determine if perceptual speech measures distinguish people with Parkinson’s (PD), 
multiple system atrophy with predominant parkinsonism (MSA-P) and progressive 
supranuclear palsy (PSP).   
Methods 
Speech-language therapists blind to patient characteristics employed clinical rating scales to 
evaluate speech/voice in 24 people with clinically diagnosed PD, 17 with PSP, 9 with MSA-
P, matched for disease duration (mean 4.9 years, SD 2.2).   
Results 
No consistent intergroup differences appeared on specific speech/voice variables. People 
with PD were significantly less impaired on overall speech/voice severity. Analyses by 
severity suggested further investigation around laryngeal, resonance and fluency changes 
may characterise individual groups  
Conclusion  
MSA-P and PSP compared to PD were distinguished by severity of speech/voice 
deterioration, but individual speech/voice parameters failed to consistently differentiate 
groups.   
 
Keywords  
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Introduction 
Parkinson’s disease (PD), multiple system atrophy (MSA) and progressive supranuclear 
palsy (PSP) constitute a group of closely related disorders, in particular in respect of shared 
parkinsonian features. Their early differentiation remains a clinical challenge. This study 
concerns whether perceptual evaluation of changes in communication may support 
diagnosis.  
 
PD is the commonest subcortical degenerative neurological disorder, with around 1% of 
people over 60 years diagnosed [1]. Mean age of diagnosis falls in the mid 60s (though 
young onset PD in the 40s or younger occurs). Survival after diagnosis normally extends in 
excess of ten years. Estimates of MSA prevalence range between 5-8 per 100.000 
population, with mean age of diagnosis around 58 years and mean survival from then 
around 5-10 years [2, 3]. PSP shows a similar, possibly slightly higher, prevalence to MSA 
and similar rate of decline. Mean age at diagnosis is approximately 63-65 years [4-6].  
 
PD and MSA are synucleinopathies. The focus of pathology in PD is on the dopamine-
producing neurons of the substantia nigra, but impairment is present in other 
neurotransmitter systems and outside nigrostriatal neuronal groups. Effects of these 
pathologies are widespread through the CNS, leading to the classic motor symptoms 
(below), but also a range of non-motor disturbances. In MSA deposition of synuclein 
occurs in oligodendrocytes, in the cerebellum, pons and basal ganglia. This leads to 
proposed sub-types depending on whether cerebellar (MSA-C) or parkinsonian 
(MSA-P) symptoms predominate [2, 3]. Which site is predominantly affected may 
vary across geographical regions [7], with implications for the prevalence of 
subtypes in different continents. PSP represents a tauopathy with typical distribution of 
pathology in the basal ganglia, brainstem and frontal lobes. Several variants are recognised 
[6, 8].  
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PD is characterised by a constellation of motor symptoms - bradykinesia, tremor, rigidity 
and postural instability. These affect balance, gait, and speed and sustainability of motor 
function. Non-motor changes are also present [9, 10], including autonomic dysfunction, 
cognitive changes and sleep and mood disturbance. People with MSA may present with 
parkinsonian features of rigidity, postural instability and bradykinesia, but signs of cerebellar 
and pyramidal dysfunction also arise [2, 3], together with signs of autonomic failure [11]. The 
hallmarks of PSP include presence of parkinsonian features - bradykinesia and postural 
instability (with notable akinetic, rigid features and propensity for backwards falling). 
However, these appear alongside symptoms of other brainstem and frontal dysfunction – 
e.g. vertical gaze palsy, dysexecutive disorder – and show a rapid (relative to PD) 
progression [4, 12].  
 
Clinically, early differentiation of MSA, PSP and PD from one another can be problematical, 
with appreciable proportions of misclassification [6, 13, 14]. Although mean age of onset and 
diagnosis differ, the age ranges overlap considerably. Whilst the course of decline varies 
across MSA, PSP and PD and distinct symptoms can arise (e.g. vertical gaze palsy in PSP; 
stridor in MSA; early dysphagia in MSA and PSP), actual presentation and progression 
across patients is diverse, with heterogeneity in the relative prominence and order of 
appearance of symptoms [10, 12, 15-17]. When parkinsonian symptoms predominate early 
on clinical separation between disorders can remain especially problematic, though attempts 
have been made to identify possible differentiating biochemical or structural imaging markers 
[18].  
 
Around 80-90% of people with Parkinson’s disease (PwPD) experience voice and speech 
changes, even in the early stages [1, 2]. Dysarthria ranks amongst the first changes to affect 
people with PSP and MSA [3-6]. Understanding the nature of speech changes in these 
conditions therefore represents an important endeavour, to monitor progression, evaluate 
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impact [7, 8], measure response to pharmacological or other therapies and identify targets 
for intervention.  
 
With regards to speech and voice changes, PwPD present with hypokinetic dysarthrophonia 
[19], typified by early effects on voice (quieter) and an emerging dysprosody. These entail 
loss of loudness/intensity contrasts (giving an impression of monoloudness) and narrowing 
pitch range (leading to impression of monopitch) resulting in problems expressing 
intonational and emotional content of utterances. Speech changes usually develop later [20]. 
Rate of speech can be altered in some speakers – to slower, or with short rushes of faster 
speech. Abnormally long pauses are found. Difficulty initiating phonation or arrests of 
phonation in mid-sentence may happen, akin to freezing of gait. Speech and voice 
impairment is not purely motoric. Auditory perceptual changes play a role in the dysprosody 
[21, 22]. Furthermore, cognitive-linguistic changes affect comprehension and production of 
language, even in the absence of dementia [23].  
 
MSA and PSP portray elements of hypokinetic dysarthria [24-27]. However, they are claimed 
to be distinguished from the hypokinetic dysarthria of PD by the presence of additional voice 
and speech changes that reflect the more widespread underlying pathology. In particular, 
presence of cerebellar pathology in MSA (particularly MSA-C), with its dysrhythmia and 
dysmetria, is believed to produce a rougher voice quality, with inconsistent loudness/ 
intensity and pitch control and stress patterns of speech moving towards excess and equal 
stress [25, 27]. By contrast greater brainstem and pyramidal involvement is believed to 
create features of spastic dysarthria – lowered pitch, strained voice quality, slowed rate, 
hypernasality, laboured articulation [24, 27]. Palilalia may be a salient feature of PSP, though 
findings are variable [16, 26]. These presumed contrasts in speech and voice profile form the 
basis of claims that speech examination may play a role in the (differential) diagnosis of PD, 
MSA, PSP.  
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Previous studies have addressed this claim but have been criticised for depending on 
unblinded, single assessor evaluation, employing scoring procedures that potentially biased 
outcomes to prejudged results [24, 25], lacking comparisons between groups [24, 25, 28] 
and neglecting possible confounds in relation to disease duration and severity – though see 
[27, 29, 30]. Other variables that may separate groups (e.g. oral-facial apraxia [31] and 
language changes [32]) have been neglected.   
 
Rusz et al [33] argued that a combination of acoustic measures relating to speech rate, 
speech fluency, pauses, and pitch and amplitude fluctuations distinguished groups with PD 
from atypical Parkinsonian syndromes with 95% accuracy – albeit their analyses appear to 
have been at group and not individual patient level and the model was not tested out on a 
new set of patients. A combination of voice quality, fluency, rate and voice tremor measures 
separated PSP from MSA with around 75% accuracy. Others also found key roles of rate 
and fluency in differentiating groups [30, 33-38]. However, even in studies which claimed 
pathognomonic features, there is variability in precisely which measures vary between 
groups and their differential sensitivity and specificity can be low.  
 
Nevertheless, there is some consensus that people with PD should demonstrate hypokinetic 
dysarthria [19]; people with PSP show a mixed dysarthria with predominantly hypokinetic 
and spastic characteristics, but less prominent ataxic features [24, 26]; people with MSA 
have a tendency to less marked spastic elements but more prominent ataxic changes 
alongside hypokinetic speech [25, 27]. Few studies examined people with MSA-C vs MSA-P 
separately. Huh et al [36] found only selected acoustic features differentiated early (time 
since diagnosis around 2 years, SD1.4) PwPD and MSA-P in male speakers, but not female. 
No perceptual dimensions distinguished groups.  
 
We aimed to test whether routine clinical perceptual assessment of speech and voice, 
attuned to potential characteristics and led by the above pointers from acoustic analyses, 
Perceptual speech evaluation  
7 
 
can differentiate between people with PD, PSP and MSA-P, independent of duration and 
severity of symptoms.  
 
Methods 
Participants  
We recruited patients with either PSP, MSA-P or PD via hospital specialist movement 
disorder outpatient clinics. PD cases were defined according to the UK PD Brain Bank 
diagnostic criteria [26], probable PSP according to NINDS-SPSP criteria [39], and probable 
MSA-P according to the Consensus and Quinn criteria [40]. Diagnosis was verified by two 
neurologists checking test results, blind to the diagnostic category. Recruitment was by 
informed, voluntary consent with right to withdraw without consequences at any point, and 
followed approved stipulations from a United Kingdom National Health Service Research 
Ethics Committee.   
 
Potential participants were excluded if they showed dementia with or without a major 
depressive disorder, had a history of stroke, head injury, or developmental stuttering, were 
non-native English speakers, or were people with MSA-P with a tracheostomy. 
 
Assessment  
Assessment took place in one session in a quiet, sound deadened room at the patient’s 
home first thing in the morning.  Participants withheld their anti-parkinsonian medication from 
midnight the night before and were thus in a pragmatically defined off state. This aimed to 
reduce possible variability from differing drug regimes and medication cycles and thereby 
gain insights more closely related to underlying motor impairments.  
 
Participants produced a prolonged /a/ at their habitual intensity. They read (after silent 
rehearsal) the ‘Grandfather passage’ [41], at their habitual intensity and rate. They described 
how to make a cup of tea/coffee to provide a sample of spontaneous speech. Speech was 
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recorded with a Roland Corporation Edirol 24-bit digital recorder attached to an AKG C420 
head mounted directional MicroMic to assure constant mouth to microphone distance and 
minimise head movement artefact and ambient noise. Assessment also covered the UPDRS 
III [42] for motor status, Addenbrooke’s Cognitive Assessment (ACE-R) [43], the MADRS 
(Montgomery-Åsberg) depression screen [44], assessment of oral-facial apraxia [45] and 
sentence level language comprehension (Token Test [46]). 
 
Three speech and language therapists blind to patient identity and aims of the study 
independently carried out speech-voice ratings. They had at least 4 years’ experience 
working in specialist units where perceptual voice and speech rating were part of their daily 
routine. They received details of each speaker’s age and gender in order to judge the 
appropriateness of pitch and loudness. They could listen to tracks as often as necessary to 
form an opinion.  
 
Voice quality was rated using the GRBAS (overall Grade, Roughness, Breathiness, 
Asthenia, Strain) scales [47] based on the prolonged /a/. This set of scales is widely 
employed in the field of voice evaluation as a valid and reliable tool [48]. Evaluation of the 
appropriateness and consistency of perceived loudness, pitch, speech rate, stress 
placement, fluency, nasality, articulation and naturalness (how normal listeners perceived 
output to be) were made in relation to the first three sentences of the ‘Grandfather passage’. 
Rating of speech fluency, nasality, articulation and naturalness were based on 7 point equal 
appearing interval scales (EAIs) (1 representing unaffected). Where non-normality might 
deviate in two directions (e.g. pitch variability towards monotone vs towards inappropriate 
variability) EAIs were 13 point with normality graded as 7 and deviations either side 
representing ‘less’ or ‘excessive’ variability. .  
 
Fluency was also quantified by counting appropriate (i.e. occurring at normal 
syntactic/semantic junctures) and inappropriate (i.e. in-word or interrupted verb or noun 
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phrase) pauses (of >200ms) and repetitions, a) when reading the entire ’Grandfather’ 
passage and b) from the spontaneous speech sample (making a cup of tea/coffee). 
Immediate single (e.g. f-frock; m-my; immed-mediate) or multiple iterations of a sound, 
syllable, word, or phrase counted as repetitions.  Three or more immediate repetitions were 
operationally classed as palilalia (e.g. grandfather father father father).  
 
Diagnostic intelligibility testing followed the format of the Assessment of Intelligibility in 
Dysarthric Speech [49], adjusted to the accent of the local population. There were 60 items. 
For each item a word was randomly selected from a set of six minimally varying words (e.g. 
Buzz, Bus, Budge, Bun, Bud, Butt). For scoring, for each item listeners circled which word 
they believed they heard from the recordings from a written choice of 12 options. These 
consisted of the six minimally differing words plus six further foils – so for the item involving 
the six words above the selection was ‘Bun, Moon, Budge, Botch, Bond, Buzz Bus, Bowl, 
Butt, Boss, Mud, Bud’. The additional words minimise possible learning effects and chance 
recognition.  
 
To provide a measure of intelligibility to general listeners three raters unfamiliar with 
dysarthric speech but familiar with the local accent audited randomly ordered tracks 
independently, blind to speaker characteristics and the purpose of the study. Each item was 
played once only in a quiet room through a DENON 205SE amplifier and Celestion 7 
speakers. The final intelligibility score was the mean number of words correctly identified 
across the three listeners from the 60 items.  
 
In addition to word identification, listeners graded ease of listening (EOL) for each item 
(amount of perceived effort required to decipher what was said) (1 extremely easy 7 
extremely difficult). EOL was calculated from the mean rating across all items per speaker.  
 
Statistical Analysis 
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Groups were matched for duration (time since diagnosis) and gender proportion. Given the 
typical age distribution of the different disorders it was not possible to match for age. 
Analyses of variance (with method depending on parametricity of data for different analyses) 
with adjusted post-hoc comparisons were employed to look at differences between groups. 
Bivariate correlations were used to look at associations between factors. Significance level 
was set at p = 0.05. Tests were two-tailed. Analyses were carried out using SPSS version 
22.  
 
Three Grandfather Passage samples were repeated without the listeners’ knowledge to 
investigate intra-rater reliability. Intraclass correlation was used to examine inter-rater 
agreement on the perceptual scales.  
 
Results 
Nine people with MSA-P (3 female), seventeen with PSP (6 female) and twenty-four with PD 
(8 female) were recruited. Summary descriptive data appear in table 1 
 
Table 1 about here 
 
Groups did not differ significantly for duration or gender proportions. People with MSA-P 
were significantly younger (p = 0.009) than those with PSP, but not than those with PD (p = 
0.084).  For UPDRS III all paired differences were statistically significant (MSA-P vs PSP p = 
0.04; MSA-P vs PD: p = 0.001; PSP vs PD: p = 0.006).  
 
The groups with MSA-P and PSP were significantly more affected on UPDRS III Speech 
rating (Table 1) than those with PD, but equally impaired to each other. Word identification 
and ease of listening scores reflected this (table 2), with no significant differences between 
PSP and MSA-P groups but significant differences (p = 0.001) between them and those with 
PD. 
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Table 2 bout here 
 
The profile of depression (none to mild) was comparable across groups. People with PSP 
generated significantly fewer words than those with PD on the ACE-R Word Fluency subtest 
(PD mean 9.5, SD 2.9, PSP mean 6.1, SD 3.7; MSA-P mean 8.8, SD 3.0; PSP vs PD:  p  
<0.01). No other ACE-R subtest or total scores differed significantly.  
 
On the oral-facial apraxia test, those with PSP were significantly more impaired than other 
groups on the upper face tasks: PSP vs MSA-P: p = 0.014; PSP vs PD: p <0.001 - with no 
significant difference between people with MSA-P vs PD (Table 3). For lower face items 
people with MSA-P (p <0.01) and with PSP (p <0.001) were significantly poorer than people 
with PD, with no significant difference between those with MSA-P and PSP.  
 
Five people with MSA-P, four with PSP and 20 with PD showed no or borderline upper face 
apraxia (score ≥38). Five with MSA-P, six with PSP, twenty-two with PD showed 
no/borderline lower face apraxia (score ≥400). People with PSP were proportionally 
significantly more likely to show oral-facial apraxia than people with PD (upper, chi = 12.30, 
p = 0.001; lower, chi = 13.23, p <0.001). The PD vs MSA groups did not differ significantly 
on upper face, and were borderline for lower, (chi = 3.57, p = 0.059). The groups with PSP 
vs MSA-P did not differ significantly on lower face scores.  
 
Groups overall were only mildly affected on the Token Test. There were significant raw score 
differences between groups (PSP poorest) but the significance disappeared when adjusted 
for age. There were members in all groups who showed no impairment on the Token Test.  
 
Table 3 about here 
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Voice and speech perceptual ratings  
The speech-language clinician raters showed high intra-rater agreement for the repeated 
samples (r 0.895, r 0.918, r 0.975). For inter-rater reliability intraclass correlation coefficients 
for average measures ranged from low for loudness consistency (0.176), roughness (0.112) 
and breathiness (0.176), through mid for strain (0.380), asthenia (0.462), to high and very 
high for grade (0.570), pitch consistency (0.586), pitch level (0.643), nasality (0.719), rate 
(0.787), loudness level (0.872), fluency rating (0.883), stress (0.898), naturalness (0.916) 
and articulation (0.943).  
 
Outcomes for the perceptual ratings of speech and voice appear in Tables 4 and 5. All 
speech rating paired comparisons were non-significant except PwPD were perceived as 
significantly more monotone (less stress prominence) than those with PSP (p = 0.04); 
people with PSP were perceived as more dysfluent than PwPD (p = 0.04); PwPD were 
judged to have significantly clearer articulation than people with MSA-P (p <0.001) and PSP 
(p <0.01). People with MSA-P and PSP had perceived poorer loudness and pitch control, but 
not statistically significant. People with MSA-P were perceived to have significantly lower 
speech naturalness than those with PD (p = 0.002).  
 
On the voice ratings mean scores consistently favoured the PwPD. However, only one 
comparison reached statistical significance - people with PSP were poorer than those with 
PD on overall Grade (p = 0.01). One other comparison approached significance (MSA-P vs 
PD on overall Grade, p = 0.06). All others were non-significant.  
 
Table 4 about here 
  
Table 5 about here 
 
Fluency measures 
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In spontaneous speech there were no significant differences between groups in the number 
of appropriate and inappropriate pauses, nor total dysfluencies, or mean length of utterance. 
Four people with PSP but none with MSA-P or PD made palilalic repetitions.  
 
On the reading passage all groups showed a similar number of appropriate pauses. Those 
with PSP (mean 7.2, SD 5.5) displayed significantly more inappropriate pauses (p = 0.008) 
than PwPD (mean 3.3, SD 3.1), but no significant difference from people with MSA-P (mean 
6.7, SD 4.9). The difference between MSA-P and PD groups approached significance (p = 
0.06).  
 
For total dysfluencies the group with PSP (mean 4.1, SD 3.1) showed significantly higher 
occurrences (p <0.001) than PwPD (mean 1.3, SD 2.3), but not significantly more than 
people with MSA-P (mean 2.4, SD 2.8). Palilalic repetitions occurred only in four individuals 
with PSP, and one single instance in someone with PD.  
 
Speech and voice contrasts by severity 
Above comparisons are based on groups matched for duration. To examine the possible 
influence of severity, data were examined in relation to overall motor score (UPDRS III total), 
and to word-recognition intelligibility score, as a measure of overall speech severity. Due to 
gross imbalance of severity rankings within and across groups in the cohort it was not 
possible to conduct reliable analyses of variance.  
 
Taking all groups together the following variables correlated (near) significantly with UPDRS 
III total score (Spearman’s): word-recognition intelligibility (r 0.417, p = 0.005), pitch 
consistency (r 0.295, p = 0.055), articulation (r 0.681, p <0.001), nasality (r 0.411, p = 0.006), 
Grade (r 0.371, p = 0.014), Roughness (r 0.332, p = 0.03) and naturalness (r 0.593, p 
<0.001).  
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Within the separate groups individuals with MSA-P showed significant correlations between 
UPDRS III and voice Breathiness (r 0.681, p <0.05) and naturalness (r 0.704, p = 0.03). 
Roughness (r 0.644, p = 0.061) approached significance. For the PSP group perceived 
speech fluency (r 0.655, p = 0.008), articulation (r 0.689, p = 0.005) and naturalness (r 
0.554, p = 0.03) correlated significantly with UPDRS III total scores. There were no 
significant correlations between UPDRS III totals and speech and voice ratings for the group 
with Parkinson’s.  
 
Groups were divided into less and more affected subgroups based on the median UPDRS III 
total score across all groups (cut-off score 39). Comparisons (Mann-Whitney) within the PSP 
group between milder (n = 5) and more severe showed significant deterioration for ACE-R 
Word fluency (p = 0.014), with borderline (p = 0.06) differences for Token Test, ACE-R 
language and oral-facial apraxia. For the speech and voice measures only speech fluency (p 
= 0.003), articulation (p = 0.019) and naturalness (p = 0.013) differed significantly. For the 
group with Parkinson’s (milder n = 18) the less vs more affected participants differed 
significantly on lower oral-facial apraxia (p = 0.036) but no other measures. As there was 
only one person in the milder group for MSA-P comparisons were not made.  
 
The following variables correlated at or near significance (Spearman’s) with the word-
recognition intelligibility score when including all groups together: Loudness consistency (r 
0.413, p = 0.006), pitch consistency (r 0.420, p = 0.005), articulation (r 0.741, p <0.001), 
nasality (r 0.444, p = 0.003), naturalness (r 0.532, p <0.001), voice Grade (r 0.556, p = 
<0.001), Breathiness (r 0.423, p = 0.005). Roughness (r 0.285, p = 0.064) and Asthenia (r 
0.284, p = 0.065) approached significance.  
 
Groups were examined independently. For those with MSA-P deterioration in loudness 
consistency (r 0.738, p = 0.037), articulation (r 0.857, p = 0.007), nasality (r 0.862, p = 
0.006), Breathiness (r 0.970, p <0.001), Asthenia (r 0.712, p = 0.048), and naturalness (r 
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0.814, p = 0.014) correlated significantly with declining intelligibility. In the PSP group pitch 
level (r 0.526, p = 0.053), articulation (r 0.625, p = 0.017), nasality (r 0.561, p = 0.037), 
naturalness (r 0.573, p = 0.032) correlated (near) significantly with intelligibility. Perceived 
speech fluency was r 0.490, p = 0.076. For those with PD only pitch consistency (moving to 
more monotone) r 0.425, p = 0.055) approached significance.  
 
The subgroups were divided by median word recognition score for the whole cohort (cut-off 
49). Only two people with MSA-P and one with PSP fell into the milder group, only four with 
PD in the more severe group. Individual subgroup analyses were therefore not conducted. 
Comparing the milder versus more affected participants for all groups combined, the 
following differences were (near) significant: articulation (p <0.001), Grade (p = 0.002), 
Roughness (p = 0.021), Breathiness (p = 0.055), naturalness (p = 0.022). No other 
differences approached significance.  
 
 
Discussion 
We aimed to examine whether selected perceptual voice and speech variables separate 
speakers with PD, PSP and MSA-P. With groups matched for duration, perceptual speech 
and voice ratings were unable to differentiate groups, contrary to earlier claims [24-27]. 
There was no indication that groups differed on rating scales that would be likely to detect 
differences suggestive of added elements of spastic or ataxic dysarthria in the groups with 
PSP and MSA-P. In particular GRBAS voice quality ratings of Strain, Roughness and 
Asthenia, prime candidates for variation across groups, did not differ; neither did loudness 
control, nasality, or perceived rate. Speech fluency was more disrupted in people with PSP 
both on objective counts and listener overall perception.  
 
PSP is characterised by the development of prominent cognitive changes. Links have been 
made between PSP and progressive aphasia, as well as presence of a possible dynamic 
aphasia [50, 51]. The lower performance on ACE-R word generation may tie in with this, and 
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more dysfluent speech can be related to word retrieval and syntax issues. However, whilst 
people with PSP performed more poorly on the language measure, the differences did not 
reach statistical significance when controlled for age. Whether language impairments may 
have contributed to more speech dysfluencies is unclear here. The fact that pause types and 
dysfluencies did not differ significantly between groups in the spontaneous speech task, but 
did so in reading, suggests not, but further testing is required to settle this. For instance, 
dysfluency in reading may relate to emerging cognitive changes associated particularly with 
PSP and/or oculomotor or visual perceptual processing disturbances. Speech apraxia can 
disrupt fluency. We only assessed for oral-facial and not speech apraxia, oculomotor 
impairment or other visual disturbances.   
 
Some studies link apraxia to PD and other movement disorders. In the current cohorts 
presence of oral-facial apraxia marked out the group with PSP as more affected, and may 
thus be an early indicator of more than just cortical basal degeneration [31]. Again, in all 
groups there were members who showed no evidence of oral-facial apraxia.  
 
The overriding impression was that where groups did differ, when matched for duration, this 
rested on inter-related measures that capture overall severity – i.e. intelligibility scores, 
articulation, naturalness and GRBAS Grade scale - rather than discrete speech/voice 
variables (though the ‘Strain’ scale on GRBAS has been noted as producing least interrater 
agreement [48], so this factor cannot be excluded here). This may simply reflect that 
progression in PSP and MSA is faster, thus people with PD look different on speech profiles 
solely because their changes remain milder. The view concurs with [27] who initially claimed 
that perceptual features separated people with MSA vs PSP, but later concluded that this 
rested more on severity related differences. The lack of correspondence between UPDRS III 
scores and speech measures is a finding across several studies, which may derive from the 
dependence of speech motor control on non-dopaminergic systems. Here it may also arise 
from the mild nature UPDRS III and speech impairment in the PD group.  
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An alternative interpretation could be that much of what looks like severity difference rests 
on elements of spasticity or ataxia complicating the milder hypokinetic speech status. These 
may be what give listeners the impression, particularly for people with PSP, of less natural, 
slower and more dysfluent speech and more impaired articulation and intelligibility than 
people with PD. Possible corroboration of this comes from studies that found speech 
diadochokinetic rate performance [30, 33, 34] sensitive to group differences, where slower 
and more dysrhythmic performance may stem from spastic and ataxic elements. Tykalová et 
al [52] also showed that a finer grained examination of consonant production may reveal 
different underlying mechanisms of disruption.  
 
There was some evidence to support this in the present speakers. Whilst measures of voice 
quality and specific aspects of pitch and loudness performance and resonance did not 
separate groups significantly based on duration, looking at changes by severity differences 
between less and more affected individuals hinted at possible subgroup characteristic 
patterns of deterioration and may tie in more closely with acoustic study findings [29, 33, 34, 
36]. People with MSA-P showed increased laryngeal impairment, manifest in poorer 
loudness consistency and weaker, more breathy voice quality [53]. Increased nasality also 
featured. People with PSP showed growing difficulty controlling pitch and greater nasality - 
arguably suggesting increased vocal cord and soft palate spasticity, though again further 
investigations are required to confirm this. Poorer word generation and speech fluency was 
also present in people with PSP.  
 
However, within the current cohort at least, claims are tempered by the fact that across 
practically all measures intra-group variability was as marked as inter-group variability. 
Individuals may thus display ‘classic’ added spasticity/ataxia, but equally others do not, and 
this leads to the negative outcomes when comparing groups as a whole. This may also 
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reflect the inconsistency across acoustic studies for which measures precisely separate 
groups.      
 
The absence of a clear qualitative difference between groups questions whether aiming to 
detect such distinctions is a fruitful task. Acoustic analysis measures discrete sound 
variables, none of which alone corresponds to human auditory perception. Both perceptual 
and acoustic analyses rest on the final audible signal. This represents a complex composite 
of influences from multiple interacting sources within the vocal tract and the listener’s 
perceptual sets. Whilst listeners can detect gradations of rate, intensity, pitch, precision and 
so forth, they can show poor agreement on presence and/or severity of changes [54-56]. 
This has been a chief criticism of the work that championed the assertion that there are 
direct localising links between speech features and site of CNS changes [41]. Attempts to 
replicate their dysarthria categories and the rank order of features meant to characterise 
them have proved elusive [55, 56]. Accuracy of syndrome/disorder detection by expert 
listeners based on speech judgements shows very low levels of agreement [57, 58], 
reflecting more ongoing issues around watertight clinical differential diagnosis [14]. 
 
Lansford et al [59] conducted a study asking listeners blind to medical aetiology or possible 
dysarthria type to assign speakers with motor speech disorders to classificatory categories. 
The resultant clusters did not match the hypokinetic, ataxic and mixed flaccid-spastic 
groupings predicted from the medical aetiologies. Rather, differences clustered around 
contrasts in rate and intelligibility of speech and vocal quality. Kim et al [60] reached similar 
conclusions in their study with speakers who included those with PD and MSA. They found 
that classification by dysarthria type produced poorest accuracy, whereas classification by 
severity matched disease classification much more closely. This appears to be the case in 
the present study where we did not find evidence that one can separate speakers on 
isolated dysarthria classificatory features but severity appeared to be a key variable.  
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Thus, earlier claims that there are distinct perceptually detectable differences between 
people with PD, PSP, MSA appear unsupported. Nevertheless, anecdotally clinicians do 
maintain they are able to detect who has PSP or MSA rather than PD. Their optimism may 
be due to the unblinded nature of speech/voice judgements and availability of other clues 
e.g. gaze palsy. However, it is also possible that they can detect features within a complex 
acoustic signal that have not been isolatable acoustically or on perceptual rating scales. This 
suggests a positive way forwards in understanding the uniqueness of speech changes in 
different disorders is to employ analytical methods that capture the totality of the speech 
signal. Promising inroads have been established using linear and non-linear analyses and 
machine learning methods [61-66] based on simple prolonged vowel sound data or brief 
mobile phone delivered speech samples. This provides a possible important route out of the 
acoustic/perceptual impasse.      
 
Some aspects of the current study may have coloured results and invite clarificatory 
investigations. Apart from the objective fluency measures, judgments were based on a single 
prolonged /a/ and three sentences from a read passage. Other vowels were not included, 
nor comparison with results based on spontaneous speech. We did not conduct detailed 
narrow phonetic analyses of the nature of articulatory changes (see [52]), nor include 
differentiation of dysarthric from speech apraxic changes. Principally this was because even 
if possible differences emerged, such labour intensive exercises are unlikely to prove 
clinically feasible – though recently attempts have been made to employ more automatized 
screening (above). Participants here were predominantly in the relatively early stages of 
progression and we excluded dementia severe enough to preclude informed consent, as 
well as people with major depression. Some of the speech features alleged to distinguish 
groups may not develop until later in the disease course.  
 
The fact that we included only MSA-P participants and not MSA-C may have influenced the 
likelihood of detecting ataxic features and detecting distinctions between MSA and PD.  
Perceptual speech evaluation  
20 
 
Previous research points to uncertainties in speech-voice differentiation between PwPD and 
MSA-P [36] and suggests, along with findings here, that more optimistic conclusions of 
others regarding separation of syndromes may be influenced by studying an undifferentiated 
group of MSA-P and MSA-C. To maintain viable numbers in groups for comparison and 
given the ongoing flux in diagnostic criteria for pathological and speech subgroups, we did 
not differentiate between possible phenotypical subgroups of PSP or MSA [8, 36].  
 
Finally, some studies [27, 29, 33, 36] have noted the possibility that female speakers may be 
less severely affected in voice and speech than males, especially in the earlier stages. We 
had similar proportions of female to male patients across groups, but this may be a variable 
to control or examine more closely in future studies.    
 
The one clear conclusion is that when matched for disease duration groups with MSA-P and 
PSP are significantly more impaired when speaking than people with PD. It underlines the 
finding that even if one cannot clinically detect a qualitatively different speech profile, then an 
early and rapidly deteriorating speech-voice picture is indicative of atypical Parkinson’s [67, 
68]. It emphasizes that the presence of early articulation changes, rather than just voice 
deterioration, suggests atypical Parkinsonism. Clinically, this finding stresses the importance 
of regular planned reviews for such patients within speech-language therapy services to 
chart rate and patterns of change.  
 
Higher numbers of inappropriate pauses in reading are suggestive of atypical Parkinson’s. 
Present findings agree partially with other studies [16, 33] that suggest repetitions and 
palilalic iterations are more likely associated with PSP than the other conditions. The status 
of palilalia as a distinguishing feature, though, remains uncertain. In different studies it is not 
always clear precisely what counted as palilalia. Even in studies that monitored palilalia it 
occurred in less than 40% of speakers [9,63]. Others have not found prominent palilalia [26]. 
In the present study palilalia did not occur in all speakers with PSP.  
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Conclusion 
Whilst diagnosis of PSP, MSA and PD may become obvious at later stages, in the crucial 
early phase differentiation remains a challenge clinically, with not insignificant rates of mis- 
or uncertain diagnosis associated with the prominence of shared Parkinson’s features. The 
heterogeneity of presentation of the three disorders and possible subtypes within disorders, 
and the considerable individual patient variability in presentation and time-course of 
appearance of symptoms also pose challenges to study design – e.g. as in this study, for 
precise matching by duration, especially early on. The low prevalence of MSA and PSP and 
the proportion of participants who can supply complete data sets means that recruitment for 
statistically sufficiently powerful studies is difficult and points to multicentre collaborations as 
a way forward.  
 
When differentiating changes to variables such as voice quality and speech rate, one must 
also consider the issues around possible changes to these that can happen in the normal 
course of ageing. Thus control groups of neurologically unaffected people should be 
included to test out the viability of chosen factors argued to identify neurological impairment.  
 
Together with indications from recent acoustic evaluations, this study offers possible 
productive variables to pursue in such a programme: measures of speech fluency; reasons 
for less impaired articulation in PD compared to MSA-P and PSP; bases of poorer 
intelligibility and naturalness in MSA-P, with the possibility of examining prosody features 
and automatized detection of these in speech [66]. Employment of acoustic approaches that 
capture the full speech signal, rather than isolated parameters, offers another direction. 
Given that isolated systems analyses are seldom conclusive in differentiation clinically, and 
diagnosis relies on constellations of co-occurring features, discriminant analyses that 
combine voice, speech, language and non-speech measures (e.g. of oral-facial apraxia, 
handwriting, eye movement, balance and gait) should prove fruitful. Finally, longitudinal 
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studies of spoken output that track the gradual emergence of distinguishing speech-voice 
characteristics are lacking but represent a promising direction of research.      
 
Summary points 
 
 Differentiating between idiopathic Parkinson’s patients from those with Progressive 
Supranuclear Palsy or Multiple System Atrophy has important prognostic and 
therapeutic implications.  
 
 Some have claimed perceptual, naked ear, evaluation of speech and voice changes 
can assist differential diagnosis. Presence of other impairments, such as oral-facial 
apraxia, language impairment and other cognitive changes may alert to an atypical 
Parkinson’s syndrome. 
 
 To test out these possibilities we compared speech and voice output, oral-facial 
apraxia and screening of language comprehension in people with PD, PSP, MSA-P 
matched for disease duration. 
 
 No consistent and significant differences emerged in terms of identifying predicted 
added spastic and ataxic dysarthria in the groups with PSP and MSA-P compared to 
people with PD; language performance did not differ significantly, but people with 
PSP were more affected by oral-facial apraxia than other groups. Groups did differ 
significantly on overall measures of performance (articulation, intelligibility, overall 
voice impairment), and variables did emerge as possible markers of severity in 
these groups. 
 
 We argue that differences in our findings compared to other studies relate partly to 
methodological drawbacks of some earlier reports but also to the nature of the 
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acoustic signal and its perception by listeners. 
 
 Investigating measures that capture the acoustic signal in its entirety rather than 
focus on isolated sub-features may prove a fruitful line of enquiry.  
 
 Clinically, the presence of early and more rapid deterioration of articulation, 
intelligibility and naturalness of speech and voice in the context of hypokinetic 
changes and the higher probability of oral-facial apraxia can be taken as indicators 
of a possible PSP or MSA-P.  
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Measure PD PSP MSA-P 
Mean  
Range 
SD 
 
Mean 
Range 
SD Mean 
Range 
SD 
Age years 67.77 
48-87 
10.19 70.94 
55-85 
6.73 58.8 
44-83 
10.9 
Years since 
diagnosis  
5.03 
3-11 
1.95 5.06 
2-10 
2.19 4.1 
1-9 
2.98 
UPDRS III Total 
0 normal - 104 
31.79 
17-55 
9.83 44.29 
18-67 
13.45 57.0 
34-81 
14.2 
UPDRS Speech  
0 normal - 4 
1.04 
0-2 
1.03 2.47 
1-3 
0.62 2.8 
 1-4 
0.97 
MADRS,  
0 (normal) - 60 
11.71 
5-25 
5.30 13.71 
2-27 
8.42 16.44 
4-27 
6.39 
ACE-R total 
100 unaffected  
86.4 
68-97 
8.65 81.3 
53-95 
11.00 89.33 
75-97 
7.61 
Table 1: Summary group data for demographic variables and general assessments. SD, 
standard deviation. 
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 PD PSP MSA-P 
Mean 
Range 
SD Mean 
Range 
SD Mean 
Range 
SD 
WR (0-60 
higher better) 
51.7 
39-59 
4.5 34.9 
15-55 
13.8 39.5 
26-49 
7.3 
EOL  
1 mild – 7  
1.9 
1-4 
0.85 4.6 
2-7 
1.9 4.0 
3-6 
1.0 
Table 2: Intelligibility scores by word recognition (WR), ease of listening (EOL)  
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 PD PSP MSA-P 
Mean 
Range 
SD Mean 
Range 
SD Mean 
Range 
SD 
OFA upper  
Max 45; cut-off 38 
42.4 
28-45 
5.15 29.8 
8-45 
11.11 39.7 
23-45 
7.6 
OFA  lower  
Max 435, cut-off 400 
424.9 
362-435 
18.5 351.5 
216-435 
61.5 373.7 
295-435 
50.6 
TT age adjusted  
Max 50 normal 
48.8 
25-50 
5.13 46.1 
35-50 
6.39 49.9 
49-50 
0.35 
Table 3: Oral-facial apraxia (OFA) and Token Test (TT) scores.  
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 PD PSP MSA-P 
Mean 
Range 
SD Mean 
Range 
SD Mean 
Range 
SD 
Loudness level 
7 normal 
5.6 
3-7 
1.2 4.5 
2-9 
1.9 6.2 
2-10 
2.6 
Loudness 
consistency 
7 normal  
6.0 
4-7 
1.1 4.8 
3-7 
1.8 5.5 
2-8 
1.2 
Pitch level 
7 normal 
7.5 
6-9 
0.9 7.8 
6-9 
1.2 7.4 
6-10 
1.2 
Pitch consistency 
7 normal 
6.2 
4-8 
1.1 4.8 
2-8 
1.9 5.9 
4-7 
1.1 
Stress 
prominence 
7 normal 
2.9 
1-7 
2.4 4.8 
1-8 
2.3 3.8 
2-7 
1.6 
Perceived speech 
rate 7 normal 
7.0 
4-10 
1.0 7.0 
4-10 
1.7 7.1 
3-10 
2.2 
Speech fluency 1 
mild - 7 
3.8 
1-6 
2.1 5.2 
1-7 
2.6 4.0 
1-6 
1.8 
 
Articulation 
1 mild - 7 
1.4 
1-3 
0.5 4.0 
1-7 
2.0 3.6 
1-7 
1.8 
Nasality 
1 mild - 7 
2.1 
1-5 
1.3 3.0 
1-5 
1.3 2.4 
1-5 
1.2 
Naturalness 
1 mild -7 
2.4 
1-5 
1.1 3.6 
1-7 
2.2 4.9 
2-7 
1.8 
Table 4: Mean group perceptual ratings across three listeners for selected speech output 
variables.   
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GRBAS 
 
0 normal-3 
PD PSP MSA-P 
Mean 
Range 
SD Mean 
Range 
SD Mean 
Range 
SD 
Grade 0.9 
0-2 
0.61 1.5 
1-3 
0.66 1.5 
1-3 
0.64 
Roughness 0.6 
0-2 
0.4 
 
0.6 
0-2 
0.5 0.9 
0-2 
0.4 
Breathiness 0.9 
0-2 
0.5 1.2 
0-2 
0.6 1.2 
0-2 
0.6 
Asthenia 0.9 
0-2 
0.6 1.4 
0-2 
0.8 1.4 
0-3 
0.9 
Strain 0.5 
0-1 
0.4 0.6 
0-2 
0.4 1.2 
0-2 
1.0 
Table 5:  Mean group ratings across three listeners for voice quality.  
